Royalty Pharma reported total assets of $19.82B and total liabilities of $10.03B for the quarter ended Jun 2026, up 8.2% year over year. This balance sheet covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||
| Cash & Short-Term Funds | |||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 1,800.81M | 1,541.05M | 1,791.52M | 2,108.04M | 991.63M | 1,710.75M | 1,975.69M | 2,173.08M | 936.45M | 477.01M | 843.00M | 1,764.64M | 950.05M | 929.03M | 1,087.72M | 631.91M | 938.94M | 618.70M | 586.40M | 811.99M | |||||||||
| Short-term InvestmentsInvestments (Current) | 245.75M | 581.87M | 484.22M | 363.70M | 409.35M | 24.42M | 2.50M | 5.10M | 5.30M | 18.30M | 29.00M | 38.50M | 48.50M | 58.20M | 12.10M | 13.20M | 16.10M | 18.80M | 21.90M | 25.00M | |||||||||
| Cash & Current Investments | 2,046.55M | 2,122.92M | 2,275.74M | 2,471.74M | 1,400.98M | 1,735.17M | 1,978.19M | 2,178.18M | 941.75M | 495.31M | 872.00M | 1,803.14M | 998.55M | 987.23M | 1,099.82M | 645.11M | 955.04M | 637.50M | 608.30M | 836.99M | |||||||||
| Securities | |||||||||||||||||||||||||||||
| Securities - Available for Sale | 255.70M | 270.40M | 304.40M | 383.00M | 739.25M | 225.10M | 257.40M | 340.30M | 347.60M | 454.50M | 499.48M | 646.40M | 701.20M | 739.62M | 213.20M | 257.90M | 307.50M | 428.70M | |||||||||||
| Other Assets | |||||||||||||||||||||||||||||
| Goodwill | 924.63M | 924.63M | 924.63M | 924.63M | 923.54M | ||||||||||||||||||||||||
| Intangibles | 11.47M | 5.67M | |||||||||||||||||||||||||||
| Goodwill & Intangibles | 11.47M | 5.67M | 924.63M | 924.63M | 924.63M | 924.63M | 923.54M | ||||||||||||||||||||||
| Long-Term Investments | 473.05M | 435.39M | 418.15M | 412.08M | 409.86M | 397.18M | 384.33M | 384.30M | 378.29M | 437.10M | 473.70M | 629.90M | 657.30M | 693.50M | 336.21M | 275.91M | 302.50M | 419.00M | 406.80M | 372.10M | |||||||||
| Other Assets | 4.52M | 4.15M | 3.87M | 33.41M | 30.61M | 29.63M | 28.03M | 29.41M | 20.21M | 6.52M | 4.49M | 27.56M | 42.79M | 33.53M | 36.71M | 85.49M | 86.59M | 79.29M | 76.85M | 62.96M | |||||||||
| Assets | 17,732.36M | 17,515.87M | 17,378.89M | 17,740.41M | 17,672.61M | 16,813.47M | 17,074.12M | 17,121.48M | 15,855.52M | 16,381.85M | 16,130.89M | 17,656.58M | 18,042.24M | 18,222.72M | 17,608.26M | 18,323.00M | 19,347.28M | 19,620.78M | 19,815.42M | 19,819.77M | |||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Borrowings | |||||||||||||||||||||||||||||
| Short term Debt | 996.58M | 997.51M | 998.44M | 999.37M | 996.94M | 997.77M | 998.61M | 999.44M | 380.00M | 380.00M | 380.00M | 380.00M | |||||||||||||||||
| Long-Term Debt | 7,090.67M | 7,096.07M | 7,101.14M | 7,106.20M | 7,111.26M | 7,116.32M | 7,121.38M | 7,126.44M | 6,131.19M | 6,135.29M | 6,139.38M | 7,602.02M | 7,607.38M | 7,612.43M | 7,617.45M | 8,002.50M | 8,945.74M | 8,950.92M | 8,956.44M | 8,961.89M | |||||||||
| Non-Current Debt | 7,090.67M | 7,096.07M | 7,101.14M | 7,106.20M | 6,114.68M | 6,118.81M | 6,122.94M | 6,127.07M | 6,131.19M | 6,135.29M | 6,139.38M | 7,602.02M | 6,610.44M | 6,614.65M | 6,618.85M | 7,003.06M | 8,565.74M | 8,570.92M | 8,576.44M | 8,581.89M | |||||||||
| Other Liabilities | |||||||||||||||||||||||||||||
| Accounts Payables | 9.19M | 5.62M | 6.66M | 12.18M | 16.11M | 7.91M | 6.66M | 5.81M | 13.63M | 15.17M | 11.55M | 23.42M | 22.06M | 13.37M | 37.63M | 20.21M | 41.42M | 19.40M | 25.48M | 35.57M | |||||||||
| Accumulated Expenses | 16.73M | 57.70M | 13.20M | 54.16M | 13.20M | 54.16M | 13.20M | 54.16M | 12.60M | 51.68M | 12.60M | 56.25M | 38.41M | 98.06M | 19.22M | 85.61M | 29.04M | 110.82M | 25.30M | 107.77M | |||||||||
| Other Accumulated Expenses | 12.40M | 11.38M | 9.02M | 97.49M | 31.20M | 68.60M | 18.60M | 3.08M | 3.12M | 53.16M | 17.48M | 16.32M | |||||||||||||||||
| Other Liabilities | 43.70M | 9.90M | 2.50M | 12.30M | 8.50M | 11.30M | 0.90M | 3.22M | 27.04M | 5.58M | 12.08M | 17.90M | 610.47M | 629.88M | 698.71M | 766.46M | 821.24M | ||||||||||||
| Total Liabilities | 7,345.72M | 7,267.32M | 7,237.01M | 7,332.23M | 7,256.20M | 7,288.09M | 7,252.12M | 7,307.80M | 6,270.43M | 6,297.56M | 6,267.17M | 7,904.76M | 7,783.78M | 7,880.35M | 7,830.60M | 8,829.06M | 9,726.42M | 9,905.84M | 9,878.58M | 10,034.06M | |||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||
| Common Stock | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | |||||||||
| Additional Paid-In CapitalAPIC | 3,454.22M | 3,507.53M | 3,543.20M | 3,570.59M | 3,632.90M | 3,666.16M | 3,739.66M | 4,031.24M | 4,006.76M | 4,011.44M | 4,074.85M | 4,100.55M | 4,107.74M | 4,103.48M | 4,210.53M | 4,127.67M | 4,112.54M | 4,123.09M | 4,384.06M | 4,376.27M | |||||||||
| Retained Earnings | 2,320.88M | 2,255.18M | 2,224.68M | 2,446.13M | 2,504.97M | 1,964.69M | 2,216.81M | 2,252.95M | 2,134.68M | 2,517.58M | 2,427.45M | 2,378.25M | 2,764.69M | 2,845.65M | 2,480.66M | 2,222.75M | 2,304.31M | 2,356.32M | 2,507.09M | 2,459.09M | |||||||||
| Accumulated Other Comprehensive IncomeAOCI | 20.55M | 16.49M | 12.30M | 13.18M | 16.90M | ||||||||||||||||||||||||
| Treasury Stock | 2.69M | 2.72M | 2.74M | 2.75M | 2.79M | 2.81M | 2.83M | 2.63M | 2.62M | 2.63M | 2.65M | 2.66M | 2.66M | 2.66M | 2.65M | 2.61M | 2.61M | 2.61M | 2.71M | 2.72M | |||||||||
| Common Equity | 10,386.63M | 10,248.55M | 10,141.88M | 10,408.19M | 10,416.40M | 9,525.37M | 9,822.00M | 9,813.69M | 9,585.10M | 10,084.29M | 9,863.72M | 9,751.82M | 10,258.47M | 10,342.37M | 9,777.66M | 9,493.94M | 9,620.86M | 9,714.94M | 9,936.83M | 9,785.71M | |||||||||
| Minority Interest | 4,593.56M | 4,471.95M | 4,364.32M | 4,380.94M | 4,264.30M | 3,897.22M | 3,868.25M | 3,532.02M | 3,446.18M | 3,557.79M | 3,363.97M | 3,275.57M | 3,388.59M | 3,395.79M | 3,100.01M | 3,155.03M | 3,206.51M | 3,238.04M | 3,048.29M | 2,952.98M | |||||||||
| Liabilities and Shareholders Equity | 17,732.36M | 17,515.87M | 17,378.89M | 17,740.41M | 17,672.61M | 16,813.47M | 17,074.12M | 17,121.48M | 15,855.52M | 16,381.85M | 16,130.89M | 17,656.58M | 18,042.24M | 18,222.72M | 17,608.26M | 18,323.00M | 19,347.28M | 19,620.78M | 19,815.42M | 19,819.77M | |||||||||
| Additional items | |||||||||||||||||||||||||||||
| Total Debt | 7,090.67M | 7,096.07M | 7,101.14M | 7,106.20M | 7,111.26M | 7,116.32M | 7,121.38M | 7,126.44M | 6,131.19M | 6,135.29M | 6,139.38M | 7,602.02M | 7,607.38M | 7,612.43M | 7,617.45M | 8,002.50M | 8,945.74M | 8,950.92M | 8,956.44M | 8,961.89M |
Pull Royalty Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RPRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RPRX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RPRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();